Results 61 to 70 of about 277 (133)
Brachytherapy in the Management of Uveal Melanomas
Uveal melanoma is the most common intraocular tumor in adults. Clinical studies have shown similar patient survival rates after treatment of medium-sized melanomas when comparing plaque brachytherapy with radioactive iodine-125 versus enucleation. This
Samuray Tuncer
doaj +1 more source
A novel quality assurance system for eye plaque brachytherapy
Eye Plaque brachytherapy pre-treatment quality assurance (QA) conducted clinically involves an activity verification of individual seeds via well chamber and does not include a physical measurement of dose-rate of the final assembly. A novel spectroscopic, dose-rate detection system, was evaluated for pre-treatment QA of eye plaque brachytherapy.
Alannah Kejda +4 more
openaire +4 more sources
High-Dose-Rate Yttrium-90 (90Y) Episcleral Plaque Brachytherapy for Iris and Iridociliary Melanoma
Purpose: To describe a pilot study on the use of single-session, high-dose-rate, Food and Drug Administration–cleared, yttrium-90 (Y90) plaque brachytherapy for iris and iridociliary melanoma. Design: A single-center, clinical case series.
Paul T. Finger, MD
doaj +1 more source
To present the American Brachytherapy Society (ABS) guidelines for plaque brachytherapy of choroidal melanoma and retinoblastoma.An international multicenter Ophthalmic Oncology Task Force (OOTF) was assembled to include 47 radiation oncologists, medical physicists, and ophthalmic oncologists from 10 countries.
Simpson, ERand +45 more
openaire +2 more sources
Magnetic resonance imaging metal artifact reduction for eye plaque patient with dental braces
Purpose : To determine if metal artifact reduction can minimize magnetic susceptibility artifacts in the orbits for an eye plaque brachytherapy patient with metallic dental braces.
H. Michael Gach +6 more
doaj +1 more source
Purpose: To evaluate the efficacy and safety of brachytherapy in patients with uveal melanoma and retinal vascular tumors. Methods: Patients who received Ruthenium-106 (Ru-106) plaque brachytherapy at the Torfeh Medical Center between March 2016 and ...
Saeed Karimi +3 more
doaj +1 more source
LASER PHOTOCOAGULATION FOR I 125 RADIATION-INDUCED RETINOPATHY IN CHOROIDAL MELANOMA: A CASE REPORT
A 25 year-old female complaining of visual acuity loss in her left eye (OS). Funduscopic and ultrasound appearance revealed choroidal melanoma in OS. Treatment with plaque brachytherapy using I125 was started.
Miriam García Fernández +2 more
doaj +1 more source
Precision Radiation Oncology, Volume 9, Issue 4, Page 232-233, December 2025.
Fada Guan +3 more
wiley +1 more source
Samuel K Houston,1 Nisha V Shah,1 Christina Decatur,1 Marcela Lonngi,1 William Feuer,1 Arnold M Markoe,2 Timothy G Murray1–31Department of Ophthalmology, 2Department of Radiation Oncology, Bascom Palmer Eye Institute, University of Miami Miller
Houston SK +6 more
doaj
Palladium-103 plaque radiation therapy for retinal angioma
Purpose: Plaque radiation has been used in the treatment of angiomas of the choroid, retina, and vasoproliferative tumors of the retina. Herein, is presented the novel use of palladium-103 (103Pd) plaque radiation as primary treatment for retinal angioma.
Paul T. Finger +5 more
doaj +1 more source

